Masimo's O3 regional oximetry device has been cleared by the FDA for delta cHb, delta HHb and delta O2Hb, providing greater visibility into changes in the deoxyhemoglobin and oxyhemoglobin components used in determining cerebral oxygen saturation.
Masimo's O3 regional oximetry device cleared for 3 more indices
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.